|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07K 14/705 | (2006.01) |
| A61K 38/00 | (2006.01) | ||
| A61K 38/19 | (2006.01) |
| (11) | Number of the document | 3134430 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15721089.9 |
| Date of filing the European patent application | 2015-04-23 | |
| (97) | Date of publication of the European application | 2017-03-01 |
| (45) | Date of publication and mention of the grant of the patent | 2018-03-21 |
| (46) | Date of publication of the claims translation | 2018-05-10 |
| (86) | Number | PCT/US2015/027270 |
| Date | 2015-04-23 |
| (87) | Number | WO 2015/164588 |
| Date | 2015-10-29 |
| (30) | Number | Date | Country code |
| 201461983152 P | 2014-04-23 | US |
| (72) |
HILL, Oliver, DE
GIEFFERS, Christian, DE
THIEMANN, Meinolf, DE
BUCHANAN, Fritz, G., US
PHILLIPS, Darren, C., US
LAPPE, Susan, E., US
|
| (73) |
Abbvie Inc.,
1 North Waukegan Road, North Chicago, IL 60064,
US
Apogenix AG, Im Neuenheimer Feld 584, 69120 Heidelberg, DE |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Viengubos grandinės TRAIL receptoriaus agonisto baltymai |
| SINGLE-CHAIN TRAIL-RECEPTOR AGONIST PROTEINS |
| Payment date | Validity (years) | Amount | |
| 2023-04-06 | 9 | 208.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2024-04-23 |